Description

IGF1-LR3 (Long Arg3 Insulin-Like Growth Factor-1) is a modified peptide analogue of the naturally occurring IGF-1 protein. Structural changes — including the substitution of an arginine at position 3 and the addition of 13 amino acids at the N-terminus — greatly reduce its binding to IGF-binding proteins, resulting in a significantly extended half-life and enhanced biological stability compared to native IGF-1.

Supplied as a 1 mg vial of lyophilized powder, IGF1-LR3 is commonly used in laboratory environments to investigate cellular proliferation, tissue growth pathways, protein synthesis, nutrient partitioning, and metabolic regulation. Its prolonged activity makes it suitable for advanced cellular and biochemical research models involving growth factor signaling and regenerative biology.

Key Features:

• Synthetic IGF-1 analogue with extended activity.

• Reduced affinity for IGF binding proteins for prolonged efficacy.

• High-purity, lyophilized peptide suitable for in-vitro and controlled research.

⚠️ Important Notice: This product is for research and laboratory use only and not intended for therapeutic, diagnostic, clinical, or personal use in humans or animals. Always follow proper laboratory safety protocols and storage instructions to maintain peptide integrity.